Studies on the Activation Mechanism of Fibrinolytic Enzyme System in Plasma by Human Pancreatic Elastase

N Toki; S Takasugi; K Ishizu; H Sato; H Sumi

doi:10.1055/s-0038-1657114

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1982; 47(01): 008-013
DOI: 10.1055/s-0038-1657114

Original Article

Schattauer GmbH Stuttgart

Studies on the Activation Mechanism of Fibrinolytic Enzyme System in Plasma by Human Pancreatic Elastase

Authors

N Toki

^*The Department of Dermatology, Hiroshima University School of Medicine, Hiroshima, Japan
S Takasugi

^**The Department of Surgery, Hiroshima University School of Medicine, Hiroshima, Japan
K Ishizu

^*The Department of Dermatology, Hiroshima University School of Medicine, Hiroshima, Japan
H Sato

^***The Zeria Pharmaceutical Co., Ltd, Itabashi Lab., Tokyo, Japan
H Sumi

^****The Department of Physiology, Miyazaki Medical College, Miyazaki, Japan

Abstract

PDF Download

Summary

In the present study, the activation mechanism of fibrinolytic enzyme system in plasma by human pancreatic elastase was investigated. It was confirmed that human pancreatic elastase not only converted the co-existing plasminogen to low molecular weight-plasminogen which could be easily activated by the activator, but also inhibited α₂-macroglobulin and α₂-plasmin inhibitor which are antiactivators or fast reacting antiplasmins, and consequently, induced the activation of the fibrinolytic enzyme system in plasma.

Key words

Elastase - Pancreatitis - Plasmin - α₂-macroglobulin - α₂-plasmin inhibitor

PDF (1259 kb)

References

References
1 Dreiling DA, Blum L, Sanders M. Thrombophlebitis, blood coagulation and pancreatic disease. A study of the pancreatic secretion in patients with thrombophlebitis. Arch, Int Med 1955; 96: 490-495
2 Shinowara GY, Stutman LJ, Walters II, Routh ME, Walker EJ. Hypercoagulability in acute pancreatitis. Am J Surg 1963; 105: 714-719
3 Gabryelewicz A, Niewiarowski S. Activation of blood clotting and inhibition of fibrinolysis in acute pancreatitis. Thrombos Diathes Haemorrh 1968; 20: 409-414
4 Kwaan HC, Anderson MC, Gramatica L. A study of pancreatic enzymes as a factor in the pathogenesis of disseminated intravascular coagulation during acute pancreatitis. Surgery 1971; 69: 663-672
5 Takasugi S, Toki N, Sumi H. Studies on a kallikrein-kinin system in plasma of patients with acute pancreatitis. The preparation and characterization of a kallikrein-like enzyme in patient’s plasma. Clin Biochem 1980; 13: 156-159
6 Toki N, Takasugi S, Sumi H. Isolation and characterization of pancreatic elastase from plasma of patients with acute pancreatitis. Clin Sci, in press
7 Sottrup-Jensen L, Claeys H, Zajdel M, Petersen TE, Magnusson S. The primary structure of human plasminogen: Isolation of two lysinebinding fragments and one »mini-« plasminogen (MW, 38,000) by elastase-catalyzed-specific limited proteolysis. Progress in Chemical Fibrinolysis and Thrombolysis. 1978. Vol. 3 191-209 edited by Davidson JF, Rowan RM, Samama MM, Desnoyers PC. Raven Press; New York:
8 Shotton D, Elastase M. In: Methods in Enzymology. 1970. 19 113-140 Academic Press; New York:
9 Largmann C, Brodrick JW, Geokas MC. Purification and characterization of two human pancreatic elastase. Biochemistry 1976; 15: 2491-2500
10 Toki N, Ishihara H, Yamura T. Prevention of plasmin autodigestion by human plasma α₂-macroglobulin. Scand J Haematol 1977; 19: 281-286
11 Toki N, Takasugi S, Sumi H, Yamura T. Studies on the effect of plasminogen activator for interaction between α₂-macroglobulin and plasmin. Thromb Haemostas 1978; 40: 377-386
12 Steinbuch M, Quetin M, Pajaudier L. Specific technique for the isolation of human α₂-macroglobulin. Nature 1965; 205: 1227-1228
13 Moroi M, Aoki N. Isolation and characterization of α₂-plasmin inhibitor from human plasma. J Biol Chem 1976; 251: 5956-5965
14 Hestrin S. The reaction of acetylcholine and other carboxylic acid derivatives with hydroxylamine, and its analytical application. J Biol Chem 1949; 180: 249-261
15 Roberts PS. Measurement of the rate of plasmin action on synthetic substrates. J Biol Chem 1958; 232: 285-291
16 Toki N, Sumi H, Takasugi S. Purification and characterization of kallikrein from plasma of patients with acute pancreatitis. Clin Sci 1981; 60: 199-205
17 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275
18 Weber K, Osborn N. The reliability of molecular weight determination by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem 1969; 244: 4406-4412
19 Davis BJ. Disc electrophoresis. II. Method and application to human serum protein. Ann New York Acad Sci 1964; 121: 404-427
20 Toki N. Studies on the mechanism of thrombolysis. On the activation of plasminogen and behavior of activated plasmin in plasma. Hiroshima Med J 1979; 27: 1-16 (in Japanese)
21 Takasugi S. Studies on the interaction of proteinases and their inhibitors in plasma of patients with acute pancreatitis. Interaction of elastase and proteinase inhibitors. Hiroshima Med J 1981; 29: 739-759 (in Japanese)
22 Baumstark JS. Studies on the elastase-serum protein interaction. II. On the digestion of human α₂-macroglobulin, an elastase inhibitor, by elastase. Biochim Biophys Acta 1970; 207: 318-330
23 Rowley PT, Sevilla ML, Schwartz RH. Serum α₁-antitrypsin types. Elastase inhibition versus trypsin inhibition. Human Heredity 1974; 24: 472-481
24 Ohlsson K, Laurell CB. The disappearance of enzyme-inhibitor complexes from the circulation of man. Clin Sci Mol Med 1976; 51: 87-92
25 Meyer J, Bieth J, Metais P. On the inhibition of elastase by serum. Some distinguishing properties of a α₁-antitrypsin and α₂-macroglobulin. Clin Chim Acta 1975; 62: 43-45